We have located links that may give you full text access.
Nucleated red blood cells indicate high risk of in-hospital mortality.
Journal of Laboratory and Clinical Medicine 2002 December
The presence of nucleated red blood cells (NRBCs) in the blood of patients with a variety of severe diseases is known to be highly associated with increased mortality. Blood analyzers to routinely measure NRBC concentrations are now available. However, the prognostic significance of such measurements has not been evaluated. Using a Sysmex XE-2100 (Sysmex; Norderstedt, Germany), we measured NRBC concentrations in 15,541 blood samples from 4,173 patients at a university clinic over the course of 12 weeks. NRBCs were found at least once in 7.5% of all patients. The highest incidence (20.0%) was found in patients from the intensive care unit of the general and accident surgery. The incidence of NRBC increased with age. The mortality of NRBC-positive patients (n = 313) was 21.1% (n = 66); this was significantly higher (P <.001) than the mortality of NRBC-negative patients (1.2%, n = 3,860). Mortality increased with increasing NRBC concentration. With regard to in-hospital mortality, NRBCs in blood showed sensitivity and specificity of 57.9% and 93.9%, respectively. NRBCs were detected for the first time, on average, 21 days (median 13 days) before death. The routine analysis of NRBCs in blood is of high prognostic power with regard to in-hospital mortality. This parameter may serve as an early indicator of patients at increased risk.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app